Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

Published:2007-04-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Horvath Karl¹,Jeitler Klaus¹,Berghold Andrea²,Ebrahim Susanne H³,Gratzer Thomas W⁴,Plank Johannes¹,Kaiser Thomas⁵,Pieber Thomas R¹,Siebenhofer Andrea⁶

Affiliation:

1. Medical University of Graz; Department of Internal Medicine; Auenbruggerplatz 15 Graz Austria 8036

2. Medical University of Graz; Institute for Medical Informatics, Statistics and Documentation; Engelgasse 13 Graz Austria 8010

3. Institute for Quality and Efficiency in Health Care; Dillenburger Str. 27 Cologne Germany 51105

4. Medical University Graz; Department of Internal Medicine; Auenbruggerplatz 15 Graz Austria 8036

5. IQWiG; Koln Germany

6. Medical University of Graz; Department of Internal Medicine and Institute for Medical Informatics, Statistics and Documentation; Auenbruggerplatz 15 Graz Austria 8036

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005613.pub3/epdf/full

Reference52 articles.

1. Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride;Eliaschewitz;Archives of Medical Research,2006

2. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.[see comment];Fritsche;Annals of internal medicine,2003

3. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes;Haak;Diabetes, obesity & metabolism,2005

4. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes;Hermansen;Diabetes care,2006

5. A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes;Massi;Hormone & Metabolic Research,2003

Cited by 318 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Impact of Intensifying Treatment from Human to Analogue Insulin on Glycaemic Control and Insulin Expenditure in Patients with Type 2 Diabetes: A Retrospective Cohort Study;Malaysian Journal of Medical Sciences;2024-04-23

2. Insulin Management in Patients With Diabetes Receiving Hemodialysis: Unanswered Questions and Way Forward;American Journal of Kidney Diseases;2024-01

3. Improvement of blood glucose control and reduction of hypoglycemia, body weight, and C-reactive protein in type 1 diabetic patients treated with intensive insulin therapy with insulin analogs;Vojnosanitetski pregled;2024

4. Hypoglycemia in Adults;Canadian Journal of Diabetes;2023-10

5. Insulin Glargine Associated Nausea in a Patient Seen by a Collaborative Drug Therapy Management Pharmacist in an Urban Community Hospital: A Case Report;Hospital Pharmacy;2023-08-04